Insider Transactions in Q2 2023 at Pax Medica, Inc. (PXMD)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 26
2023
|
Howard J. Weisman Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,952
-1.38%
|
$9,952
$1.61 P/Share
|
Apr 26
2023
|
Zachary Rome Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,272
-1.61%
|
$6,272
$1.61 P/Share
|
Apr 26
2023
|
John F Coelho Director |
SELL
Payment of exercise price or tax liability
|
Direct |
389
-0.48%
|
$389
$1.61 P/Share
|
Apr 26
2023
|
Karen La Rochelle Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,802
-3.19%
|
$1,802
$1.61 P/Share
|
Apr 26
2023
|
Michael Derby > 10% Shareholder |
SELL
Payment of exercise price or tax liability
|
Direct |
6,272
-1.32%
|
$6,272
$1.61 P/Share
|
Apr 13
2023
|
Charles J Casamento Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+17.59%
|
-
|
Apr 13
2023
|
John F Coelho Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+14.7%
|
-
|
Apr 13
2023
|
Michael Derby > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+24.02%
|
-
|
Apr 13
2023
|
Karen La Rochelle Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+19.88%
|
-
|
Apr 13
2023
|
Zachary Rome Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+20.47%
|
-
|
Apr 13
2023
|
Stephen Sheldon CFO and COO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+28.57%
|
-
|
Apr 13
2023
|
Howard J. Weisman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
180,000
+19.96%
|
-
|